Global Physiologically Active Peptides Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Physiologically Active Peptides market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Physiologically Active Peptides Industry Forecast” looks at past sales and reviews total world Physiologically Active Peptides sales in 2023, providing a comprehensive analysis by region and market sector of projected Physiologically Active Peptides sales for 2024 through 2030. With Physiologically Active Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Physiologically Active Peptides industry.
This Insight Report provides a comprehensive analysis of the global Physiologically Active Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Physiologically Active Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Physiologically Active Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Physiologically Active Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Physiologically Active Peptides.
United States market for Physiologically Active Peptides is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Physiologically Active Peptides is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Physiologically Active Peptides is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Physiologically Active Peptides players cover American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Physiologically Active Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Physiologically Active Peptides market?
What factors are driving Physiologically Active Peptides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Physiologically Active Peptides market opportunities vary by end market size?
How does Physiologically Active Peptides break out by Type, by Application?
The global Physiologically Active Peptides market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Physiologically Active Peptides Industry Forecast” looks at past sales and reviews total world Physiologically Active Peptides sales in 2023, providing a comprehensive analysis by region and market sector of projected Physiologically Active Peptides sales for 2024 through 2030. With Physiologically Active Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Physiologically Active Peptides industry.
This Insight Report provides a comprehensive analysis of the global Physiologically Active Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Physiologically Active Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Physiologically Active Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Physiologically Active Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Physiologically Active Peptides.
United States market for Physiologically Active Peptides is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Physiologically Active Peptides is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Physiologically Active Peptides is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Physiologically Active Peptides players cover American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Physiologically Active Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Antimicrobial Peptides
- Neuroactive Peptides
- Immunoactive Peptides
- Antioxidant Peptides
- Others
- Food and Beverages
- Cosmetics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- American Peptide Company Inc.
- Phermpep Co. Ltd.
- ALEXIS Corporation
- Merck KGaA
- Promega Corporation
- Advanced Bioconcept Company
- Arlak Biotech
- WN Pharmaceuticals Ltd.
- Anaspec Inc.
- Thermo Fisher Scientific
- Seagarden AS
- Novo Nordisk A/S
What is the 10-year outlook for the global Physiologically Active Peptides market?
What factors are driving Physiologically Active Peptides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Physiologically Active Peptides market opportunities vary by end market size?
How does Physiologically Active Peptides break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Physiologically Active Peptides Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Physiologically Active Peptides by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Physiologically Active Peptides by Country/Region, 2019, 2023 & 2030
2.2 Physiologically Active Peptides Segment by Type
2.2.1 Antimicrobial Peptides
2.2.2 Neuroactive Peptides
2.2.3 Immunoactive Peptides
2.2.4 Antioxidant Peptides
2.2.5 Others
2.3 Physiologically Active Peptides Sales by Type
2.3.1 Global Physiologically Active Peptides Sales Market Share by Type (2019-2024)
2.3.2 Global Physiologically Active Peptides Revenue and Market Share by Type (2019-2024)
2.3.3 Global Physiologically Active Peptides Sale Price by Type (2019-2024)
2.4 Physiologically Active Peptides Segment by Application
2.4.1 Food and Beverages
2.4.2 Cosmetics
2.4.3 Others
2.5 Physiologically Active Peptides Sales by Application
2.5.1 Global Physiologically Active Peptides Sale Market Share by Application (2019-2024)
2.5.2 Global Physiologically Active Peptides Revenue and Market Share by Application (2019-2024)
2.5.3 Global Physiologically Active Peptides Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Physiologically Active Peptides Breakdown Data by Company
3.1.1 Global Physiologically Active Peptides Annual Sales by Company (2019-2024)
3.1.2 Global Physiologically Active Peptides Sales Market Share by Company (2019-2024)
3.2 Global Physiologically Active Peptides Annual Revenue by Company (2019-2024)
3.2.1 Global Physiologically Active Peptides Revenue by Company (2019-2024)
3.2.2 Global Physiologically Active Peptides Revenue Market Share by Company (2019-2024)
3.3 Global Physiologically Active Peptides Sale Price by Company
3.4 Key Manufacturers Physiologically Active Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Physiologically Active Peptides Product Location Distribution
3.4.2 Players Physiologically Active Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHYSIOLOGICALLY ACTIVE PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Physiologically Active Peptides Market Size by Geographic Region (2019-2024)
4.1.1 Global Physiologically Active Peptides Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Physiologically Active Peptides Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Physiologically Active Peptides Market Size by Country/Region (2019-2024)
4.2.1 Global Physiologically Active Peptides Annual Sales by Country/Region (2019-2024)
4.2.2 Global Physiologically Active Peptides Annual Revenue by Country/Region (2019-2024)
4.3 Americas Physiologically Active Peptides Sales Growth
4.4 APAC Physiologically Active Peptides Sales Growth
4.5 Europe Physiologically Active Peptides Sales Growth
4.6 Middle East & Africa Physiologically Active Peptides Sales Growth
5 AMERICAS
5.1 Americas Physiologically Active Peptides Sales by Country
5.1.1 Americas Physiologically Active Peptides Sales by Country (2019-2024)
5.1.2 Americas Physiologically Active Peptides Revenue by Country (2019-2024)
5.2 Americas Physiologically Active Peptides Sales by Type (2019-2024)
5.3 Americas Physiologically Active Peptides Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Physiologically Active Peptides Sales by Region
6.1.1 APAC Physiologically Active Peptides Sales by Region (2019-2024)
6.1.2 APAC Physiologically Active Peptides Revenue by Region (2019-2024)
6.2 APAC Physiologically Active Peptides Sales by Type (2019-2024)
6.3 APAC Physiologically Active Peptides Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Physiologically Active Peptides by Country
7.1.1 Europe Physiologically Active Peptides Sales by Country (2019-2024)
7.1.2 Europe Physiologically Active Peptides Revenue by Country (2019-2024)
7.2 Europe Physiologically Active Peptides Sales by Type (2019-2024)
7.3 Europe Physiologically Active Peptides Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Physiologically Active Peptides by Country
8.1.1 Middle East & Africa Physiologically Active Peptides Sales by Country (2019-2024)
8.1.2 Middle East & Africa Physiologically Active Peptides Revenue by Country (2019-2024)
8.2 Middle East & Africa Physiologically Active Peptides Sales by Type (2019-2024)
8.3 Middle East & Africa Physiologically Active Peptides Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Physiologically Active Peptides
10.3 Manufacturing Process Analysis of Physiologically Active Peptides
10.4 Industry Chain Structure of Physiologically Active Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Physiologically Active Peptides Distributors
11.3 Physiologically Active Peptides Customer
12 WORLD FORECAST REVIEW FOR PHYSIOLOGICALLY ACTIVE PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Physiologically Active Peptides Market Size Forecast by Region
12.1.1 Global Physiologically Active Peptides Forecast by Region (2025-2030)
12.1.2 Global Physiologically Active Peptides Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Physiologically Active Peptides Forecast by Type (2025-2030)
12.7 Global Physiologically Active Peptides Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 American Peptide Company Inc.
13.1.1 American Peptide Company Inc. Company Information
13.1.2 American Peptide Company Inc. Physiologically Active Peptides Product Portfolios and Specifications
13.1.3 American Peptide Company Inc. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 American Peptide Company Inc. Main Business Overview
13.1.5 American Peptide Company Inc. Latest Developments
13.2 Phermpep Co. Ltd.
13.2.1 Phermpep Co. Ltd. Company Information
13.2.2 Phermpep Co. Ltd. Physiologically Active Peptides Product Portfolios and Specifications
13.2.3 Phermpep Co. Ltd. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Phermpep Co. Ltd. Main Business Overview
13.2.5 Phermpep Co. Ltd. Latest Developments
13.3 ALEXIS Corporation
13.3.1 ALEXIS Corporation Company Information
13.3.2 ALEXIS Corporation Physiologically Active Peptides Product Portfolios and Specifications
13.3.3 ALEXIS Corporation Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ALEXIS Corporation Main Business Overview
13.3.5 ALEXIS Corporation Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Physiologically Active Peptides Product Portfolios and Specifications
13.4.3 Merck KGaA Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Promega Corporation
13.5.1 Promega Corporation Company Information
13.5.2 Promega Corporation Physiologically Active Peptides Product Portfolios and Specifications
13.5.3 Promega Corporation Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Promega Corporation Main Business Overview
13.5.5 Promega Corporation Latest Developments
13.6 Advanced Bioconcept Company
13.6.1 Advanced Bioconcept Company Company Information
13.6.2 Advanced Bioconcept Company Physiologically Active Peptides Product Portfolios and Specifications
13.6.3 Advanced Bioconcept Company Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Advanced Bioconcept Company Main Business Overview
13.6.5 Advanced Bioconcept Company Latest Developments
13.7 Arlak Biotech
13.7.1 Arlak Biotech Company Information
13.7.2 Arlak Biotech Physiologically Active Peptides Product Portfolios and Specifications
13.7.3 Arlak Biotech Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Arlak Biotech Main Business Overview
13.7.5 Arlak Biotech Latest Developments
13.8 WN Pharmaceuticals Ltd.
13.8.1 WN Pharmaceuticals Ltd. Company Information
13.8.2 WN Pharmaceuticals Ltd. Physiologically Active Peptides Product Portfolios and Specifications
13.8.3 WN Pharmaceuticals Ltd. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 WN Pharmaceuticals Ltd. Main Business Overview
13.8.5 WN Pharmaceuticals Ltd. Latest Developments
13.9 Anaspec Inc.
13.9.1 Anaspec Inc. Company Information
13.9.2 Anaspec Inc. Physiologically Active Peptides Product Portfolios and Specifications
13.9.3 Anaspec Inc. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Anaspec Inc. Main Business Overview
13.9.5 Anaspec Inc. Latest Developments
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Information
13.10.2 Thermo Fisher Scientific Physiologically Active Peptides Product Portfolios and Specifications
13.10.3 Thermo Fisher Scientific Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Thermo Fisher Scientific Main Business Overview
13.10.5 Thermo Fisher Scientific Latest Developments
13.11 Seagarden AS
13.11.1 Seagarden AS Company Information
13.11.2 Seagarden AS Physiologically Active Peptides Product Portfolios and Specifications
13.11.3 Seagarden AS Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Seagarden AS Main Business Overview
13.11.5 Seagarden AS Latest Developments
13.12 Novo Nordisk A/S
13.12.1 Novo Nordisk A/S Company Information
13.12.2 Novo Nordisk A/S Physiologically Active Peptides Product Portfolios and Specifications
13.12.3 Novo Nordisk A/S Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Novo Nordisk A/S Main Business Overview
13.12.5 Novo Nordisk A/S Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Physiologically Active Peptides Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Physiologically Active Peptides by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Physiologically Active Peptides by Country/Region, 2019, 2023 & 2030
2.2 Physiologically Active Peptides Segment by Type
2.2.1 Antimicrobial Peptides
2.2.2 Neuroactive Peptides
2.2.3 Immunoactive Peptides
2.2.4 Antioxidant Peptides
2.2.5 Others
2.3 Physiologically Active Peptides Sales by Type
2.3.1 Global Physiologically Active Peptides Sales Market Share by Type (2019-2024)
2.3.2 Global Physiologically Active Peptides Revenue and Market Share by Type (2019-2024)
2.3.3 Global Physiologically Active Peptides Sale Price by Type (2019-2024)
2.4 Physiologically Active Peptides Segment by Application
2.4.1 Food and Beverages
2.4.2 Cosmetics
2.4.3 Others
2.5 Physiologically Active Peptides Sales by Application
2.5.1 Global Physiologically Active Peptides Sale Market Share by Application (2019-2024)
2.5.2 Global Physiologically Active Peptides Revenue and Market Share by Application (2019-2024)
2.5.3 Global Physiologically Active Peptides Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Physiologically Active Peptides Breakdown Data by Company
3.1.1 Global Physiologically Active Peptides Annual Sales by Company (2019-2024)
3.1.2 Global Physiologically Active Peptides Sales Market Share by Company (2019-2024)
3.2 Global Physiologically Active Peptides Annual Revenue by Company (2019-2024)
3.2.1 Global Physiologically Active Peptides Revenue by Company (2019-2024)
3.2.2 Global Physiologically Active Peptides Revenue Market Share by Company (2019-2024)
3.3 Global Physiologically Active Peptides Sale Price by Company
3.4 Key Manufacturers Physiologically Active Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Physiologically Active Peptides Product Location Distribution
3.4.2 Players Physiologically Active Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHYSIOLOGICALLY ACTIVE PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Physiologically Active Peptides Market Size by Geographic Region (2019-2024)
4.1.1 Global Physiologically Active Peptides Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Physiologically Active Peptides Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Physiologically Active Peptides Market Size by Country/Region (2019-2024)
4.2.1 Global Physiologically Active Peptides Annual Sales by Country/Region (2019-2024)
4.2.2 Global Physiologically Active Peptides Annual Revenue by Country/Region (2019-2024)
4.3 Americas Physiologically Active Peptides Sales Growth
4.4 APAC Physiologically Active Peptides Sales Growth
4.5 Europe Physiologically Active Peptides Sales Growth
4.6 Middle East & Africa Physiologically Active Peptides Sales Growth
5 AMERICAS
5.1 Americas Physiologically Active Peptides Sales by Country
5.1.1 Americas Physiologically Active Peptides Sales by Country (2019-2024)
5.1.2 Americas Physiologically Active Peptides Revenue by Country (2019-2024)
5.2 Americas Physiologically Active Peptides Sales by Type (2019-2024)
5.3 Americas Physiologically Active Peptides Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Physiologically Active Peptides Sales by Region
6.1.1 APAC Physiologically Active Peptides Sales by Region (2019-2024)
6.1.2 APAC Physiologically Active Peptides Revenue by Region (2019-2024)
6.2 APAC Physiologically Active Peptides Sales by Type (2019-2024)
6.3 APAC Physiologically Active Peptides Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Physiologically Active Peptides by Country
7.1.1 Europe Physiologically Active Peptides Sales by Country (2019-2024)
7.1.2 Europe Physiologically Active Peptides Revenue by Country (2019-2024)
7.2 Europe Physiologically Active Peptides Sales by Type (2019-2024)
7.3 Europe Physiologically Active Peptides Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Physiologically Active Peptides by Country
8.1.1 Middle East & Africa Physiologically Active Peptides Sales by Country (2019-2024)
8.1.2 Middle East & Africa Physiologically Active Peptides Revenue by Country (2019-2024)
8.2 Middle East & Africa Physiologically Active Peptides Sales by Type (2019-2024)
8.3 Middle East & Africa Physiologically Active Peptides Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Physiologically Active Peptides
10.3 Manufacturing Process Analysis of Physiologically Active Peptides
10.4 Industry Chain Structure of Physiologically Active Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Physiologically Active Peptides Distributors
11.3 Physiologically Active Peptides Customer
12 WORLD FORECAST REVIEW FOR PHYSIOLOGICALLY ACTIVE PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Physiologically Active Peptides Market Size Forecast by Region
12.1.1 Global Physiologically Active Peptides Forecast by Region (2025-2030)
12.1.2 Global Physiologically Active Peptides Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Physiologically Active Peptides Forecast by Type (2025-2030)
12.7 Global Physiologically Active Peptides Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 American Peptide Company Inc.
13.1.1 American Peptide Company Inc. Company Information
13.1.2 American Peptide Company Inc. Physiologically Active Peptides Product Portfolios and Specifications
13.1.3 American Peptide Company Inc. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 American Peptide Company Inc. Main Business Overview
13.1.5 American Peptide Company Inc. Latest Developments
13.2 Phermpep Co. Ltd.
13.2.1 Phermpep Co. Ltd. Company Information
13.2.2 Phermpep Co. Ltd. Physiologically Active Peptides Product Portfolios and Specifications
13.2.3 Phermpep Co. Ltd. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Phermpep Co. Ltd. Main Business Overview
13.2.5 Phermpep Co. Ltd. Latest Developments
13.3 ALEXIS Corporation
13.3.1 ALEXIS Corporation Company Information
13.3.2 ALEXIS Corporation Physiologically Active Peptides Product Portfolios and Specifications
13.3.3 ALEXIS Corporation Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ALEXIS Corporation Main Business Overview
13.3.5 ALEXIS Corporation Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Physiologically Active Peptides Product Portfolios and Specifications
13.4.3 Merck KGaA Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Promega Corporation
13.5.1 Promega Corporation Company Information
13.5.2 Promega Corporation Physiologically Active Peptides Product Portfolios and Specifications
13.5.3 Promega Corporation Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Promega Corporation Main Business Overview
13.5.5 Promega Corporation Latest Developments
13.6 Advanced Bioconcept Company
13.6.1 Advanced Bioconcept Company Company Information
13.6.2 Advanced Bioconcept Company Physiologically Active Peptides Product Portfolios and Specifications
13.6.3 Advanced Bioconcept Company Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Advanced Bioconcept Company Main Business Overview
13.6.5 Advanced Bioconcept Company Latest Developments
13.7 Arlak Biotech
13.7.1 Arlak Biotech Company Information
13.7.2 Arlak Biotech Physiologically Active Peptides Product Portfolios and Specifications
13.7.3 Arlak Biotech Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Arlak Biotech Main Business Overview
13.7.5 Arlak Biotech Latest Developments
13.8 WN Pharmaceuticals Ltd.
13.8.1 WN Pharmaceuticals Ltd. Company Information
13.8.2 WN Pharmaceuticals Ltd. Physiologically Active Peptides Product Portfolios and Specifications
13.8.3 WN Pharmaceuticals Ltd. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 WN Pharmaceuticals Ltd. Main Business Overview
13.8.5 WN Pharmaceuticals Ltd. Latest Developments
13.9 Anaspec Inc.
13.9.1 Anaspec Inc. Company Information
13.9.2 Anaspec Inc. Physiologically Active Peptides Product Portfolios and Specifications
13.9.3 Anaspec Inc. Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Anaspec Inc. Main Business Overview
13.9.5 Anaspec Inc. Latest Developments
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Information
13.10.2 Thermo Fisher Scientific Physiologically Active Peptides Product Portfolios and Specifications
13.10.3 Thermo Fisher Scientific Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Thermo Fisher Scientific Main Business Overview
13.10.5 Thermo Fisher Scientific Latest Developments
13.11 Seagarden AS
13.11.1 Seagarden AS Company Information
13.11.2 Seagarden AS Physiologically Active Peptides Product Portfolios and Specifications
13.11.3 Seagarden AS Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Seagarden AS Main Business Overview
13.11.5 Seagarden AS Latest Developments
13.12 Novo Nordisk A/S
13.12.1 Novo Nordisk A/S Company Information
13.12.2 Novo Nordisk A/S Physiologically Active Peptides Product Portfolios and Specifications
13.12.3 Novo Nordisk A/S Physiologically Active Peptides Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Novo Nordisk A/S Main Business Overview
13.12.5 Novo Nordisk A/S Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Physiologically Active Peptides Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Physiologically Active Peptides Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Antimicrobial Peptides
Table 4. Major Players of Neuroactive Peptides
Table 5. Major Players of Immunoactive Peptides
Table 6. Major Players of Antioxidant Peptides
Table 7. Major Players of Others
Table 8. Global Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 9. Global Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Table 10. Global Physiologically Active Peptides Revenue by Type (2019-2024) & ($ million)
Table 11. Global Physiologically Active Peptides Revenue Market Share by Type (2019-2024)
Table 12. Global Physiologically Active Peptides Sale Price by Type (2019-2024) & (US$/Ton)
Table 13. Global Physiologically Active Peptides Sale by Application (2019-2024) & (Tons)
Table 14. Global Physiologically Active Peptides Sale Market Share by Application (2019-2024)
Table 15. Global Physiologically Active Peptides Revenue by Application (2019-2024) & ($ million)
Table 16. Global Physiologically Active Peptides Revenue Market Share by Application (2019-2024)
Table 17. Global Physiologically Active Peptides Sale Price by Application (2019-2024) & (US$/Ton)
Table 18. Global Physiologically Active Peptides Sales by Company (2019-2024) & (Tons)
Table 19. Global Physiologically Active Peptides Sales Market Share by Company (2019-2024)
Table 20. Global Physiologically Active Peptides Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Physiologically Active Peptides Revenue Market Share by Company (2019-2024)
Table 22. Global Physiologically Active Peptides Sale Price by Company (2019-2024) & (US$/Ton)
Table 23. Key Manufacturers Physiologically Active Peptides Producing Area Distribution and Sales Area
Table 24. Players Physiologically Active Peptides Products Offered
Table 25. Physiologically Active Peptides Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Physiologically Active Peptides Sales by Geographic Region (2019-2024) & (Tons)
Table 29. Global Physiologically Active Peptides Sales Market Share Geographic Region (2019-2024)
Table 30. Global Physiologically Active Peptides Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Physiologically Active Peptides Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Physiologically Active Peptides Sales by Country/Region (2019-2024) & (Tons)
Table 33. Global Physiologically Active Peptides Sales Market Share by Country/Region (2019-2024)
Table 34. Global Physiologically Active Peptides Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Physiologically Active Peptides Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Physiologically Active Peptides Sales by Country (2019-2024) & (Tons)
Table 37. Americas Physiologically Active Peptides Sales Market Share by Country (2019-2024)
Table 38. Americas Physiologically Active Peptides Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 40. Americas Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 41. APAC Physiologically Active Peptides Sales by Region (2019-2024) & (Tons)
Table 42. APAC Physiologically Active Peptides Sales Market Share by Region (2019-2024)
Table 43. APAC Physiologically Active Peptides Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 45. APAC Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 46. Europe Physiologically Active Peptides Sales by Country (2019-2024) & (Tons)
Table 47. Europe Physiologically Active Peptides Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 49. Europe Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 50. Middle East & Africa Physiologically Active Peptides Sales by Country (2019-2024) & (Tons)
Table 51. Middle East & Africa Physiologically Active Peptides Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 53. Middle East & Africa Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 54. Key Market Drivers & Growth Opportunities of Physiologically Active Peptides
Table 55. Key Market Challenges & Risks of Physiologically Active Peptides
Table 56. Key Industry Trends of Physiologically Active Peptides
Table 57. Physiologically Active Peptides Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Physiologically Active Peptides Distributors List
Table 60. Physiologically Active Peptides Customer List
Table 61. Global Physiologically Active Peptides Sales Forecast by Region (2025-2030) & (Tons)
Table 62. Global Physiologically Active Peptides Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Physiologically Active Peptides Sales Forecast by Country (2025-2030) & (Tons)
Table 64. Americas Physiologically Active Peptides Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Physiologically Active Peptides Sales Forecast by Region (2025-2030) & (Tons)
Table 66. APAC Physiologically Active Peptides Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Physiologically Active Peptides Sales Forecast by Country (2025-2030) & (Tons)
Table 68. Europe Physiologically Active Peptides Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Physiologically Active Peptides Sales Forecast by Country (2025-2030) & (Tons)
Table 70. Middle East & Africa Physiologically Active Peptides Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Physiologically Active Peptides Sales Forecast by Type (2025-2030) & (Tons)
Table 72. Global Physiologically Active Peptides Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Physiologically Active Peptides Sales Forecast by Application (2025-2030) & (Tons)
Table 74. Global Physiologically Active Peptides Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. American Peptide Company Inc. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 76. American Peptide Company Inc. Physiologically Active Peptides Product Portfolios and Specifications
Table 77. American Peptide Company Inc. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. American Peptide Company Inc. Main Business
Table 79. American Peptide Company Inc. Latest Developments
Table 80. Phermpep Co. Ltd. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 81. Phermpep Co. Ltd. Physiologically Active Peptides Product Portfolios and Specifications
Table 82. Phermpep Co. Ltd. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Phermpep Co. Ltd. Main Business
Table 84. Phermpep Co. Ltd. Latest Developments
Table 85. ALEXIS Corporation Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 86. ALEXIS Corporation Physiologically Active Peptides Product Portfolios and Specifications
Table 87. ALEXIS Corporation Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. ALEXIS Corporation Main Business
Table 89. ALEXIS Corporation Latest Developments
Table 90. Merck KGaA Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck KGaA Physiologically Active Peptides Product Portfolios and Specifications
Table 92. Merck KGaA Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Merck KGaA Main Business
Table 94. Merck KGaA Latest Developments
Table 95. Promega Corporation Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 96. Promega Corporation Physiologically Active Peptides Product Portfolios and Specifications
Table 97. Promega Corporation Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Promega Corporation Main Business
Table 99. Promega Corporation Latest Developments
Table 100. Advanced Bioconcept Company Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 101. Advanced Bioconcept Company Physiologically Active Peptides Product Portfolios and Specifications
Table 102. Advanced Bioconcept Company Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Advanced Bioconcept Company Main Business
Table 104. Advanced Bioconcept Company Latest Developments
Table 105. Arlak Biotech Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 106. Arlak Biotech Physiologically Active Peptides Product Portfolios and Specifications
Table 107. Arlak Biotech Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Arlak Biotech Main Business
Table 109. Arlak Biotech Latest Developments
Table 110. WN Pharmaceuticals Ltd. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 111. WN Pharmaceuticals Ltd. Physiologically Active Peptides Product Portfolios and Specifications
Table 112. WN Pharmaceuticals Ltd. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. WN Pharmaceuticals Ltd. Main Business
Table 114. WN Pharmaceuticals Ltd. Latest Developments
Table 115. Anaspec Inc. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 116. Anaspec Inc. Physiologically Active Peptides Product Portfolios and Specifications
Table 117. Anaspec Inc. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Anaspec Inc. Main Business
Table 119. Anaspec Inc. Latest Developments
Table 120. Thermo Fisher Scientific Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 121. Thermo Fisher Scientific Physiologically Active Peptides Product Portfolios and Specifications
Table 122. Thermo Fisher Scientific Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Thermo Fisher Scientific Main Business
Table 124. Thermo Fisher Scientific Latest Developments
Table 125. Seagarden AS Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 126. Seagarden AS Physiologically Active Peptides Product Portfolios and Specifications
Table 127. Seagarden AS Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Seagarden AS Main Business
Table 129. Seagarden AS Latest Developments
Table 130. Novo Nordisk A/S Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 131. Novo Nordisk A/S Physiologically Active Peptides Product Portfolios and Specifications
Table 132. Novo Nordisk A/S Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. Novo Nordisk A/S Main Business
Table 134. Novo Nordisk A/S Latest Developments
Table 1. Physiologically Active Peptides Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Physiologically Active Peptides Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Antimicrobial Peptides
Table 4. Major Players of Neuroactive Peptides
Table 5. Major Players of Immunoactive Peptides
Table 6. Major Players of Antioxidant Peptides
Table 7. Major Players of Others
Table 8. Global Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 9. Global Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Table 10. Global Physiologically Active Peptides Revenue by Type (2019-2024) & ($ million)
Table 11. Global Physiologically Active Peptides Revenue Market Share by Type (2019-2024)
Table 12. Global Physiologically Active Peptides Sale Price by Type (2019-2024) & (US$/Ton)
Table 13. Global Physiologically Active Peptides Sale by Application (2019-2024) & (Tons)
Table 14. Global Physiologically Active Peptides Sale Market Share by Application (2019-2024)
Table 15. Global Physiologically Active Peptides Revenue by Application (2019-2024) & ($ million)
Table 16. Global Physiologically Active Peptides Revenue Market Share by Application (2019-2024)
Table 17. Global Physiologically Active Peptides Sale Price by Application (2019-2024) & (US$/Ton)
Table 18. Global Physiologically Active Peptides Sales by Company (2019-2024) & (Tons)
Table 19. Global Physiologically Active Peptides Sales Market Share by Company (2019-2024)
Table 20. Global Physiologically Active Peptides Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Physiologically Active Peptides Revenue Market Share by Company (2019-2024)
Table 22. Global Physiologically Active Peptides Sale Price by Company (2019-2024) & (US$/Ton)
Table 23. Key Manufacturers Physiologically Active Peptides Producing Area Distribution and Sales Area
Table 24. Players Physiologically Active Peptides Products Offered
Table 25. Physiologically Active Peptides Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Physiologically Active Peptides Sales by Geographic Region (2019-2024) & (Tons)
Table 29. Global Physiologically Active Peptides Sales Market Share Geographic Region (2019-2024)
Table 30. Global Physiologically Active Peptides Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Physiologically Active Peptides Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Physiologically Active Peptides Sales by Country/Region (2019-2024) & (Tons)
Table 33. Global Physiologically Active Peptides Sales Market Share by Country/Region (2019-2024)
Table 34. Global Physiologically Active Peptides Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Physiologically Active Peptides Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Physiologically Active Peptides Sales by Country (2019-2024) & (Tons)
Table 37. Americas Physiologically Active Peptides Sales Market Share by Country (2019-2024)
Table 38. Americas Physiologically Active Peptides Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 40. Americas Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 41. APAC Physiologically Active Peptides Sales by Region (2019-2024) & (Tons)
Table 42. APAC Physiologically Active Peptides Sales Market Share by Region (2019-2024)
Table 43. APAC Physiologically Active Peptides Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 45. APAC Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 46. Europe Physiologically Active Peptides Sales by Country (2019-2024) & (Tons)
Table 47. Europe Physiologically Active Peptides Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 49. Europe Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 50. Middle East & Africa Physiologically Active Peptides Sales by Country (2019-2024) & (Tons)
Table 51. Middle East & Africa Physiologically Active Peptides Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Physiologically Active Peptides Sales by Type (2019-2024) & (Tons)
Table 53. Middle East & Africa Physiologically Active Peptides Sales by Application (2019-2024) & (Tons)
Table 54. Key Market Drivers & Growth Opportunities of Physiologically Active Peptides
Table 55. Key Market Challenges & Risks of Physiologically Active Peptides
Table 56. Key Industry Trends of Physiologically Active Peptides
Table 57. Physiologically Active Peptides Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Physiologically Active Peptides Distributors List
Table 60. Physiologically Active Peptides Customer List
Table 61. Global Physiologically Active Peptides Sales Forecast by Region (2025-2030) & (Tons)
Table 62. Global Physiologically Active Peptides Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Physiologically Active Peptides Sales Forecast by Country (2025-2030) & (Tons)
Table 64. Americas Physiologically Active Peptides Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Physiologically Active Peptides Sales Forecast by Region (2025-2030) & (Tons)
Table 66. APAC Physiologically Active Peptides Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Physiologically Active Peptides Sales Forecast by Country (2025-2030) & (Tons)
Table 68. Europe Physiologically Active Peptides Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Physiologically Active Peptides Sales Forecast by Country (2025-2030) & (Tons)
Table 70. Middle East & Africa Physiologically Active Peptides Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Physiologically Active Peptides Sales Forecast by Type (2025-2030) & (Tons)
Table 72. Global Physiologically Active Peptides Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Physiologically Active Peptides Sales Forecast by Application (2025-2030) & (Tons)
Table 74. Global Physiologically Active Peptides Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. American Peptide Company Inc. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 76. American Peptide Company Inc. Physiologically Active Peptides Product Portfolios and Specifications
Table 77. American Peptide Company Inc. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. American Peptide Company Inc. Main Business
Table 79. American Peptide Company Inc. Latest Developments
Table 80. Phermpep Co. Ltd. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 81. Phermpep Co. Ltd. Physiologically Active Peptides Product Portfolios and Specifications
Table 82. Phermpep Co. Ltd. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Phermpep Co. Ltd. Main Business
Table 84. Phermpep Co. Ltd. Latest Developments
Table 85. ALEXIS Corporation Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 86. ALEXIS Corporation Physiologically Active Peptides Product Portfolios and Specifications
Table 87. ALEXIS Corporation Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. ALEXIS Corporation Main Business
Table 89. ALEXIS Corporation Latest Developments
Table 90. Merck KGaA Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck KGaA Physiologically Active Peptides Product Portfolios and Specifications
Table 92. Merck KGaA Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Merck KGaA Main Business
Table 94. Merck KGaA Latest Developments
Table 95. Promega Corporation Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 96. Promega Corporation Physiologically Active Peptides Product Portfolios and Specifications
Table 97. Promega Corporation Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Promega Corporation Main Business
Table 99. Promega Corporation Latest Developments
Table 100. Advanced Bioconcept Company Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 101. Advanced Bioconcept Company Physiologically Active Peptides Product Portfolios and Specifications
Table 102. Advanced Bioconcept Company Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Advanced Bioconcept Company Main Business
Table 104. Advanced Bioconcept Company Latest Developments
Table 105. Arlak Biotech Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 106. Arlak Biotech Physiologically Active Peptides Product Portfolios and Specifications
Table 107. Arlak Biotech Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Arlak Biotech Main Business
Table 109. Arlak Biotech Latest Developments
Table 110. WN Pharmaceuticals Ltd. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 111. WN Pharmaceuticals Ltd. Physiologically Active Peptides Product Portfolios and Specifications
Table 112. WN Pharmaceuticals Ltd. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. WN Pharmaceuticals Ltd. Main Business
Table 114. WN Pharmaceuticals Ltd. Latest Developments
Table 115. Anaspec Inc. Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 116. Anaspec Inc. Physiologically Active Peptides Product Portfolios and Specifications
Table 117. Anaspec Inc. Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Anaspec Inc. Main Business
Table 119. Anaspec Inc. Latest Developments
Table 120. Thermo Fisher Scientific Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 121. Thermo Fisher Scientific Physiologically Active Peptides Product Portfolios and Specifications
Table 122. Thermo Fisher Scientific Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Thermo Fisher Scientific Main Business
Table 124. Thermo Fisher Scientific Latest Developments
Table 125. Seagarden AS Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 126. Seagarden AS Physiologically Active Peptides Product Portfolios and Specifications
Table 127. Seagarden AS Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Seagarden AS Main Business
Table 129. Seagarden AS Latest Developments
Table 130. Novo Nordisk A/S Basic Information, Physiologically Active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 131. Novo Nordisk A/S Physiologically Active Peptides Product Portfolios and Specifications
Table 132. Novo Nordisk A/S Physiologically Active Peptides Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. Novo Nordisk A/S Main Business
Table 134. Novo Nordisk A/S Latest Developments
LIST OF FIGURES
Figure 1. Picture of Physiologically Active Peptides
Figure 2. Physiologically Active Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Physiologically Active Peptides Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Physiologically Active Peptides Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Physiologically Active Peptides Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Physiologically Active Peptides Sales Market Share by Country/Region (2023)
Figure 10. Physiologically Active Peptides Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Antimicrobial Peptides
Figure 12. Product Picture of Neuroactive Peptides
Figure 13. Product Picture of Immunoactive Peptides
Figure 14. Product Picture of Antioxidant Peptides
Figure 15. Product Picture of Others
Figure 16. Global Physiologically Active Peptides Sales Market Share by Type in 2023
Figure 17. Global Physiologically Active Peptides Revenue Market Share by Type (2019-2024)
Figure 18. Physiologically Active Peptides Consumed in Food and Beverages
Figure 19. Global Physiologically Active Peptides Market: Food and Beverages (2019-2024) & (Tons)
Figure 20. Physiologically Active Peptides Consumed in Cosmetics
Figure 21. Global Physiologically Active Peptides Market: Cosmetics (2019-2024) & (Tons)
Figure 22. Physiologically Active Peptides Consumed in Others
Figure 23. Global Physiologically Active Peptides Market: Others (2019-2024) & (Tons)
Figure 24. Global Physiologically Active Peptides Sale Market Share by Application (2023)
Figure 25. Global Physiologically Active Peptides Revenue Market Share by Application in 2023
Figure 26. Physiologically Active Peptides Sales by Company in 2023 (Tons)
Figure 27. Global Physiologically Active Peptides Sales Market Share by Company in 2023
Figure 28. Physiologically Active Peptides Revenue by Company in 2023 ($ millions)
Figure 29. Global Physiologically Active Peptides Revenue Market Share by Company in 2023
Figure 30. Global Physiologically Active Peptides Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Physiologically Active Peptides Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 33. Americas Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 34. APAC Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 35. APAC Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 36. Europe Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 37. Europe Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 39. Middle East & Africa Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 40. Americas Physiologically Active Peptides Sales Market Share by Country in 2023
Figure 41. Americas Physiologically Active Peptides Revenue Market Share by Country (2019-2024)
Figure 42. Americas Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 43. Americas Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 44. United States Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Physiologically Active Peptides Sales Market Share by Region in 2023
Figure 49. APAC Physiologically Active Peptides Revenue Market Share by Region (2019-2024)
Figure 50. APAC Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 51. APAC Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 52. China Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 56. India Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Physiologically Active Peptides Sales Market Share by Country in 2023
Figure 60. Europe Physiologically Active Peptides Revenue Market Share by Country (2019-2024)
Figure 61. Europe Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 62. Europe Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 63. Germany Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 64. France Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Physiologically Active Peptides Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 71. Egypt Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Physiologically Active Peptides in 2023
Figure 77. Manufacturing Process Analysis of Physiologically Active Peptides
Figure 78. Industry Chain Structure of Physiologically Active Peptides
Figure 79. Channels of Distribution
Figure 80. Global Physiologically Active Peptides Sales Market Forecast by Region (2025-2030)
Figure 81. Global Physiologically Active Peptides Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Physiologically Active Peptides Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Physiologically Active Peptides Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Physiologically Active Peptides Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Physiologically Active Peptides Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Physiologically Active Peptides
Figure 2. Physiologically Active Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Physiologically Active Peptides Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Physiologically Active Peptides Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Physiologically Active Peptides Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Physiologically Active Peptides Sales Market Share by Country/Region (2023)
Figure 10. Physiologically Active Peptides Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Antimicrobial Peptides
Figure 12. Product Picture of Neuroactive Peptides
Figure 13. Product Picture of Immunoactive Peptides
Figure 14. Product Picture of Antioxidant Peptides
Figure 15. Product Picture of Others
Figure 16. Global Physiologically Active Peptides Sales Market Share by Type in 2023
Figure 17. Global Physiologically Active Peptides Revenue Market Share by Type (2019-2024)
Figure 18. Physiologically Active Peptides Consumed in Food and Beverages
Figure 19. Global Physiologically Active Peptides Market: Food and Beverages (2019-2024) & (Tons)
Figure 20. Physiologically Active Peptides Consumed in Cosmetics
Figure 21. Global Physiologically Active Peptides Market: Cosmetics (2019-2024) & (Tons)
Figure 22. Physiologically Active Peptides Consumed in Others
Figure 23. Global Physiologically Active Peptides Market: Others (2019-2024) & (Tons)
Figure 24. Global Physiologically Active Peptides Sale Market Share by Application (2023)
Figure 25. Global Physiologically Active Peptides Revenue Market Share by Application in 2023
Figure 26. Physiologically Active Peptides Sales by Company in 2023 (Tons)
Figure 27. Global Physiologically Active Peptides Sales Market Share by Company in 2023
Figure 28. Physiologically Active Peptides Revenue by Company in 2023 ($ millions)
Figure 29. Global Physiologically Active Peptides Revenue Market Share by Company in 2023
Figure 30. Global Physiologically Active Peptides Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Physiologically Active Peptides Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 33. Americas Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 34. APAC Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 35. APAC Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 36. Europe Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 37. Europe Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Physiologically Active Peptides Sales 2019-2024 (Tons)
Figure 39. Middle East & Africa Physiologically Active Peptides Revenue 2019-2024 ($ millions)
Figure 40. Americas Physiologically Active Peptides Sales Market Share by Country in 2023
Figure 41. Americas Physiologically Active Peptides Revenue Market Share by Country (2019-2024)
Figure 42. Americas Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 43. Americas Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 44. United States Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Physiologically Active Peptides Sales Market Share by Region in 2023
Figure 49. APAC Physiologically Active Peptides Revenue Market Share by Region (2019-2024)
Figure 50. APAC Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 51. APAC Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 52. China Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 56. India Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Physiologically Active Peptides Sales Market Share by Country in 2023
Figure 60. Europe Physiologically Active Peptides Revenue Market Share by Country (2019-2024)
Figure 61. Europe Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 62. Europe Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 63. Germany Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 64. France Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Physiologically Active Peptides Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Physiologically Active Peptides Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Physiologically Active Peptides Sales Market Share by Application (2019-2024)
Figure 71. Egypt Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Physiologically Active Peptides Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Physiologically Active Peptides in 2023
Figure 77. Manufacturing Process Analysis of Physiologically Active Peptides
Figure 78. Industry Chain Structure of Physiologically Active Peptides
Figure 79. Channels of Distribution
Figure 80. Global Physiologically Active Peptides Sales Market Forecast by Region (2025-2030)
Figure 81. Global Physiologically Active Peptides Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Physiologically Active Peptides Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Physiologically Active Peptides Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Physiologically Active Peptides Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Physiologically Active Peptides Revenue Market Share Forecast by Application (2025-2030)
